Cite
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β.
MLA
Raap, Mieke, et al. “Lobular Carcinoma in Situ and Invasive Lobular Breast Cancer Are Characterized by Enhanced Expression of Transcription Factor AP-2β.” Laboratory Investigation; a Journal of Technical Methods and Pathology, vol. 98, no. 1, Jan. 2018, pp. 117–29. EBSCOhost, https://doi.org/10.1038/labinvest.2017.106.
APA
Raap, M., Gronewold, M., Christgen, H., Glage, S., Bentires-Alj, M., Koren, S., Derksen, P. W., Boelens, M., Jonkers, J., Lehmann, U., Feuerhake, F., Kuehnle, E., Gluz, O., Kates, R., Nitz, U., Harbeck, N., Kreipe, H. H., & Christgen, M. (2018). Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β. Laboratory Investigation; a Journal of Technical Methods and Pathology, 98(1), 117–129. https://doi.org/10.1038/labinvest.2017.106
Chicago
Raap, Mieke, Malte Gronewold, Henriette Christgen, Silke Glage, Mohammad Bentires-Alj, Shany Koren, Patrick W Derksen, et al. 2018. “Lobular Carcinoma in Situ and Invasive Lobular Breast Cancer Are Characterized by Enhanced Expression of Transcription Factor AP-2β.” Laboratory Investigation; a Journal of Technical Methods and Pathology 98 (1): 117–29. doi:10.1038/labinvest.2017.106.